Q2 FY27 earnings call scheduled for November 4, 2026

Board & Shareholder Meetings View source PDF Explain this filing

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹606.00

prior close

₹607.70

announcement price

In-mkt

timing

Nifty Microcap 250market-2.6%+2.4% vs market

Healthcare Service Provider peers, median of 28sector-0.7%+0.5% vs sector

On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 0.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.3

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-2.6+2.4-0.7+0.5

Next day

-0.7-3.6+2.9-0.1-0.5

-2.6-5.8+3.2-1.3-1.3

-0.7-5.5+4.8-1.6+1.0

+3.2pendingpending+0.4+2.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Management will hold an investor call at 11:00 am IST on November 4, 2026 to discuss the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The call will also cover the company's business strategy and outlook using publicly available information.

Likely market impact

Neutral. The call may provide an update on performance and outlook, but the filing contains no financial results or new business information.